{"id":"W2041814933","doi":"10.1097/jto.0b013e3181a94b08","title":"Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation","year":2009,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"Genentech; Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Erlotinib; Pharmacodynamics; Separation (statistics); Pharmacology; Oncology; Internal medicine; Pharmacokinetics; Cancer; Chemotherapy; Machine learning; Epidermal growth factor receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003276993,0.0001106914,0.0003429536,0.0004390384,0.00003740672,0.00001343313,0.00006652451,0.0000600908,0.00003965849],"category_scores_gemma":[0.00004627574,0.00007920714,0.00006018767,0.0003068644,0.00002095869,0.0001752149,0.000006693384,0.0002041404,0.00000846085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007148192,"about_ca_system_score_gemma":0.0003941475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005998749,"about_ca_topic_score_gemma":0.00002797446,"domain_scores_codex":[0.9990128,0.0001100233,0.0004132692,0.00011832,0.0001946901,0.0001509469],"domain_scores_gemma":[0.9991659,0.00005313654,0.0003103212,0.00008303514,0.000245988,0.0001416441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01442245,0.005052467,0.002213209,0.00002892227,0.0002231764,0.0007199576,0.001677249,0.0006292691,0.02682543,0.0002079455,0.0005071173,0.9474928],"study_design_scores_gemma":[0.1140571,0.3863421,0.3874757,0.002856235,0.007282535,0.006711388,0.007050634,0.01412237,0.04189286,0.003982591,0.02694461,0.001281895],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713998,0.0001443097,0.01439533,0.01222444,0.0002549326,0.0004950123,0.000002745928,0.00001135358,0.001072083],"genre_scores_gemma":[0.9819745,0.00003125993,0.01657933,0.001071447,0.0001058932,0.000010977,0.00001396492,0.000009036909,0.0002036071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9462109,"threshold_uncertainty_score":0.3229973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02243771064690426,"score_gpt":0.4925979184773803,"score_spread":0.4701602078304761,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}